Allianz Asset Management Gmb H Tg Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 29,900 shares of TGTX stock, worth $922,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,900

Holding current value

$922,415

% of portfolio

0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$17.21 - $25.28 $514,579 - $755,872	29,900 New	29,900 $699,000
Q2 2022 Aug 12, 2022	SELL	$3.74 - $10.66 $774,273 - $2.21 Million	-207,025 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.81 - $20.45 $563,733 - $1.48 Million	-72,181 Reduced 25.85%	207,025 $1.97 Million
Q4 2021 Feb 11, 2022	BUY	$15.2 - $35.51 $73,522 - $171,761	4,837 Added 1.76%	279,206 $5.31 Million
Q3 2021 Nov 10, 2021	BUY	$21.78 - $40.45 $945,121 - $1.76 Million	43,394 Added 18.79%	274,369 $9.13 Million
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $3.07 Million - $4.63 Million	94,514 Added 69.26%	230,975 $8.96 Million
Q1 2021 May 13, 2021	BUY	$41.61 - $54.3 $542,594 - $708,072	13,040 Added 10.57%	136,461 $6.58 Million
Q4 2020 Feb 16, 2021	SELL	$25.27 - $54.9 $693,737 - $1.51 Million	-27,453 Reduced 18.2%	123,421 $6.42 Million
Q3 2020 Nov 13, 2020	BUY	$18.49 - $27.24 $322,040 - $474,439	17,417 Added 13.05%	150,874 $4.04 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $228,026 - $559,562	25,621 Added 23.76%	133,457 $2.6 Million
Q1 2020 May 14, 2020	SELL	$7.14 - $15.99 $278,852 - $624,489	-39,055 Reduced 26.59%	107,836 $1.06 Million
Q4 2019 Feb 13, 2020	BUY	$5.1 - $11.2 $749,144 - $1.65 Million	146,891 New	146,891 $1.63 Million
Q4 2018 Feb 14, 2019	SELL	$3.44 - $5.76 $583,520 - $977,057	-169,628 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$5.15 - $14.0 $73,727 - $200,424	14,316 Added 9.22%	169,628 $950,000
Q2 2018 Aug 13, 2018	SELL	$12.5 - $15.0 $11,237 - $13,485	-899 Reduced 0.58%	155,312 $2.04 Million
Q1 2018 May 14, 2018	BUY	$8.7 - $16.8 $158,609 - $306,280	18,231 Added 13.21%	156,211 $2.22 Million
Q4 2017 Feb 13, 2018	BUY	$7.35 - $12.3 $63,224 - $105,804	8,602 Added 6.65%	137,980 $1.13 Million
Q3 2017 Nov 13, 2017	BUY	$10.0 - $12.7 $45,300 - $57,531	4,530 Added 3.63%	129,378 $1.53 Million
Q2 2017 Aug 14, 2017	BUY	N/A	124,848	124,848 $1.26 Million

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.48B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Tg Therapeutics, Inc. Transaction History